Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: Efficacy and safety of anti‐CD20 (rituximab) treatment

Anne Etienne, Stéphane Gayet, Florian Vidal, Pascale Poullin, Corinne Brunet, Jean‐Robert Harlé, Gilles Kaplanski

American Journal of Hematology · 2004 · 18 citations · 7 references

Concepts

Abstract

Abstract Autoimmune hemolytic anemia (AIHA) is rare and difficult to treat during chronic hepatitis C. We report herein the case of a hepatitis C patient with severe and resistant AIHA who experienced a good and sustained response with anti‐CD20 monoclonal antibody treatment. Am. J. Hematol. 75:243–245, 2004. © 2004 Wiley‐Liss, Inc.

References

7